Cargando…
A Highly Productive CHO Cell Line Secreting Human Blood Clotting Factor IX
Hemophilia B patients suffer from an inherited blood-clotting defect and require regular administration of blood-clotting factor IX replacement therapy. Recombinant human factor IX produced in cultured CHO cells is nearly identical to natural, plasma-derived factor IX and is widely used in clinical...
Autores principales: | Kovnir, S. V., Orlova, N. A., Shakhparonov, M. I., Skryabin, K. G., Gabibov, A. G., Vorobiev, I. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916734/ https://www.ncbi.nlm.nih.gov/pubmed/29713519 |
Ejemplares similares
-
Blood Clotting Factor VIII: From Evolution to Therapy
por: Orlova, N. A., et al.
Publicado: (2013) -
Coagulation Factor IX for Hemophilia B Therapy
por: Orlova, N. A., et al.
Publicado: (2012) -
Stable Expression of Recombinant Factor VIII in CHO Cells Using
Methotrexate-Driven Transgene Amplification
por: Orlova, N. A., et al.
Publicado: (2012) -
Improved elongation factor-1 alpha-based vectors for stable high-level expression of heterologous proteins in Chinese hamster ovary cells
por: Orlova, Nadezhda A, et al.
Publicado: (2014) -
Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system
por: Orlova, Nadezhda A., et al.
Publicado: (2017)